Final results from QUASAR2, a multicentre, international randomised Phase III trial of capecitabine (cap) +/- bevacizumab (bev) in the adjuvant setting of Stage II/III colorectal cancer (CRC)

Rachel Midgley; Sharon Love; Ian P.M. Tomlinson; Elaine Johnstone; Claire Scudder; Sarah Pearson; Patrick Julier; Enric Domingo; David Church; Francesco Pezzella; J. Hu; Eva Segelov; Andrew Weaver; David J Kerr

doi:10.1093/annonc/mdu438.10

Final results from QUASAR2, a multicentre, international randomised Phase III trial of capecitabine (cap) +/- bevacizumab (bev) in the adjuvant setting of Stage II/III colorectal cancer (CRC)

Rachel Midgley, Sharon Love, Ian P.M. Tomlinson, Elaine Johnstone, Claire Scudder, Sarah Pearson, Patrick Julier, Enric Domingo, David Church, Francesco Pezzella, J. Hu, Eva Segelov, Andrew Weaver, David J Kerr

Research output: Contribution to conference › Abstract

Original language	English
Number of pages	1
DOIs	https://doi.org/10.1093/annonc/mdu438.10
Publication status	Published - 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdu438.10

Cite this

Midgley, R., Love, S., Tomlinson, I. P. M., Johnstone, E., Scudder, C., Pearson, S., Julier, P., Domingo, E., Church, D., Pezzella, F., Hu, J., Segelov, E., Weaver, A., & Kerr, D. J. (2014). Final results from QUASAR2, a multicentre, international randomised Phase III trial of capecitabine (cap) +/- bevacizumab (bev) in the adjuvant setting of Stage II/III colorectal cancer (CRC). https://doi.org/10.1093/annonc/mdu438.10

@conference{478fdf7abe6a4e59892297f6cd45200a,

title = "Final results from QUASAR2, a multicentre, international randomised Phase III trial of capecitabine (cap) +/- bevacizumab (bev) in the adjuvant setting of Stage II/III colorectal cancer (CRC)",

author = "Rachel Midgley and Sharon Love and Tomlinson, {Ian P.M.} and Elaine Johnstone and Claire Scudder and Sarah Pearson and Patrick Julier and Enric Domingo and David Church and Francesco Pezzella and J. Hu and Eva Segelov and Andrew Weaver and Kerr, {David J}",

year = "2014",

doi = "10.1093/annonc/mdu438.10",

language = "English",

}

Midgley, R, Love, S, Tomlinson, IPM, Johnstone, E, Scudder, C, Pearson, S, Julier, P, Domingo, E, Church, D, Pezzella, F, Hu, J, Segelov, E, Weaver, A & Kerr, DJ 2014, 'Final results from QUASAR2, a multicentre, international randomised Phase III trial of capecitabine (cap) +/- bevacizumab (bev) in the adjuvant setting of Stage II/III colorectal cancer (CRC)'. https://doi.org/10.1093/annonc/mdu438.10

TY - CONF

T1 - Final results from QUASAR2, a multicentre, international randomised Phase III trial of capecitabine (cap) +/- bevacizumab (bev) in the adjuvant setting of Stage II/III colorectal cancer (CRC)

AU - Midgley, Rachel

AU - Love, Sharon

AU - Tomlinson, Ian P.M.

AU - Johnstone, Elaine

AU - Scudder, Claire

AU - Pearson, Sarah

AU - Julier, Patrick

AU - Domingo, Enric

AU - Church, David

AU - Pezzella, Francesco

AU - Hu, J.

AU - Segelov, Eva

AU - Weaver, Andrew

AU - Kerr, David J

PY - 2014

Y1 - 2014

U2 - 10.1093/annonc/mdu438.10

DO - 10.1093/annonc/mdu438.10

M3 - Abstract

ER -